As biologic products have expanded from the high volume requirements of recombinant proteins to personalized cell & gene therapies, technologies that support flexibility in biomanufacturing have become more critical. This panel will discuss critical success factors for leveraging new technology to increase agility, improve productivity and monitor quality.